First Trust NYSE Arca Biotechnology Index Fund
111 hedge funds and large institutions have $292M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 48 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
+4
Holders Change %
+3.74%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
15
Increased
27
Reduced
48
Closed
9
Calls
$3.62M
Puts
$2.24M
Net Calls
+$1.37M
Net Calls Change
+$228K
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$5.02M |
| 2 |
NA
Navellier & Associates
Reno,
Nevada
|
+$4.53M |
| 3 |
Morgan Stanley
New York
|
+$4.35M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.32M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.69M |
Top Sellers
| 1 |
SG Americas Securities
New York
|
-$5.75M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.3M |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2.86M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.12M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$1.74M |
